- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05804253
Maxillary Sinus Grafting With Deproteinized Porcine or Bovine Bone Mineral.
March 26, 2023 updated by: Krennmair Gerald, Camlog Oral Reconstruction Foundation
Clinical, Radiographic and Histological/Histomorphometric Analysis of Maxillary Sinus Grafting With Deproteinized Porcine or Bovine Bone Mineral: a Randomized Controlled Clinical Trial
The present study aimed to compare the histomorphometrically evaluated new bone formation, the radiographically measured graft stability and the clinical implant outcome between maxillary sinuses grafted either with deproteinized porcine bone mineral (DPBM) or deproteinized bovine bone mineral (DBBM).
Conclusions: From a clinical point of view, the present results demonstrate that DPBM provides for comparable bone formation and stable graft dimension and high implant success rates combined with healthy peri-implant condition:
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Materials and Methods: Thirty maxillary sinuses in 28 participants were initially included and randomly assigned to the test group (TG;DPBM: n=15) or the control group (CG,DBBM: n=15).
After a healing period (6 months) bone core biopsies were axially retrieved in the molar site for histological/ histomorphometrical analysis of new bone formations.
In addition, radiographically measured graft stability as well as the clinical implant outcome (implant survival/success/peri-implant health) were assessed at the 1-year and 3-year follow-up evaluations.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- maxillary sinus atrophy in the need of sinus augmentation, 2 stage augmentation procedure
Exclusion Criteria:
- drug abuse, additional augmentation procedure, heavy smokers, bisphosphonate abuse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: bovine bone
Patients received maxillary sinus augmentation grafting with bovine bone mineral
|
Maxillary sinus grafting with 2 different xenogenic materials
|
|
Active Comparator: Porcine bone mineral
patients received maxillary sinus augmentation grafting with porcine bone mineral
|
Maxillary sinus grafting with 2 different xenogenic materials
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
New bone formation
Time Frame: 3 year
|
Bone trephine specimen retrieved at implant placement were histomorphometrically analyzed. With special interest % of new bone formation,% of residual graft and % of connective tissue were evaluated and compared between bovine and porcine mineral bone used for sinus grafting. |
3 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
June 30, 2018
Study Completion (Actual)
June 30, 2018
Study Registration Dates
First Submitted
March 14, 2023
First Submitted That Met QC Criteria
March 26, 2023
First Posted (Actual)
April 7, 2023
Study Record Updates
Last Update Posted (Actual)
April 7, 2023
Last Update Submitted That Met QC Criteria
March 26, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- CamlogORF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maxillary sinus augmentation
-
ARDEC AcademyCorporacion Universitaria Rafael NunezCompleted
-
ARDEC AcademyCompletedAlveolar Bone Loss | Alveolar Bone ResorptionColombia
-
Aalborg University HospitalActive, not recruitingDental Implant FailedDenmark
-
Tokat Gaziosmanpasa UniversityCompletedMaxillary Sinus Augmentation | Posterior Maxillary AtrophyTurkey (Türkiye)
-
Aalborg University HospitalCompletedPeri-Implantitis | Patient Satisfaction | Survival, ProsthesisDenmark
-
ARDEC AcademyUniversity of Bologna; ITI International Team for Implantology, SwitzerlandCompleted
-
Kutahya Health Sciences UniversityCompletedMaxillary Sinus Disease | Sinus DiseaseTurkey
-
University of BaghdadRecruiting
-
Semmelweis UniversityInstitut Straumann AG; NSK Europe GmbH; Botiss Medical AG; Dicomlab Kft.; Hungarian... and other collaboratorsCompletedMaxillary Sinus AugmentationHungary
-
Cairo UniversityRecruiting